Commonwealth Equity Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.94M Sell
79,808
-35,136
-31% -$855K ﹤0.01% 2008
2025
Q1
$2.39M Sell
114,944
-51,752
-31% -$1.07M ﹤0.01% 1787
2024
Q4
$3.93M Sell
166,696
-99,359
-37% -$2.34M 0.01% 1396
2024
Q3
$6.81M Sell
266,055
-29,875
-10% -$765K 0.01% 1034
2024
Q2
$6.95M Sell
295,930
-44,184
-13% -$1.04M 0.01% 1001
2024
Q1
$9.78M Sell
340,114
-23,950
-7% -$689K 0.02% 796
2023
Q4
$11.9M Sell
364,064
-73,453
-17% -$2.41M 0.02% 654
2023
Q3
$12.2M Sell
437,517
-29,158
-6% -$812K 0.03% 593
2023
Q2
$15.9M Sell
466,675
-62,278
-12% -$2.12M 0.03% 494
2023
Q1
$15.9K Sell
528,953
-23,928
-4% -$719 0.03% 478
2022
Q4
$15.6M Buy
552,881
+7,666
+1% +$216K 0.04% 455
2022
Q3
$17.9M Sell
545,215
-44,484
-8% -$1.46M 0.05% 369
2022
Q2
$18.6M Sell
589,699
-2,200
-0.4% -$69.3K 0.05% 363
2022
Q1
$27.2M Sell
591,899
-1,865
-0.3% -$85.7K 0.06% 292
2021
Q4
$36.4M Sell
593,764
-77,825
-12% -$4.77M 0.08% 228
2021
Q3
$50.2M Buy
671,589
+13,371
+2% +$999K 0.13% 164
2021
Q2
$60.9M Sell
658,218
-106,506
-14% -$9.85M 0.15% 142
2021
Q1
$67.9M Buy
764,724
+144,234
+23% +$12.8M 0.19% 112
2020
Q4
$57.9M Buy
620,490
+206,272
+50% +$19.2M 0.17% 124
2020
Q3
$26.4M Buy
414,218
+109,552
+36% +$6.98M 0.09% 220
2020
Q2
$15.9M Buy
304,666
+87,434
+40% +$4.56M 0.06% 297
2020
Q1
$6.8M Buy
217,232
+35,634
+20% +$1.11M 0.03% 461
2019
Q4
$6.09M Buy
181,598
+29,041
+19% +$973K 0.02% 557
2019
Q3
$4.5M Buy
152,557
+8,429
+6% +$249K 0.02% 634
2019
Q2
$4.97M Buy
144,128
+72,704
+102% +$2.51M 0.02% 581
2019
Q1
$2.35M Buy
71,424
+18,582
+35% +$611K 0.01% 856
2018
Q4
$1.27M Buy
52,842
+5,342
+11% +$128K 0.01% 1065
2018
Q3
$1.59M Buy
47,500
+21,939
+86% +$733K 0.01% 1043
2018
Q2
$743K Buy
25,561
+15,800
+162% +$459K ﹤0.01% 1471
2018
Q1
$251K Buy
+9,761
New +$251K ﹤0.01% 2202